pubrio
Peptron logo
其他领域Founded 1997🇰🇷 韩国

SmartDepotTM is Peptron’s proprietary ultrasonic spray drying technology for the preparation of sustained release (SR) injectable microsphere formulation of drug. Recently, this long-acting technology has attracted the intense attention of global pharmaceutical companies since the costs for developing new medicines are soaring and patent expirations of many blockbuster drugs are just around the corner. SmartDepotTM is a next generation technology featuring various release profiles from 1 week to 6 months, showing high production yield and enabling mass production, differentiated from existing SR technology. SmartDepotTM is highly applicable to various peptide and small molecule drug. Patented technology ensures manufacturing and quality aspects of the competitive product development. Peptron has been developing anti-diabetes drug, anti-neurodegenerative disease drug, anti-acromegaly drug, anti-schizophrenia drug, which will be marketed in collaboration with global partners.

成立年份
1997
行业
其他领域
股票
koe: 087010.KQ
总部
🇰🇷37-24, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, Korea, Republic Of, 34054
专长
其他领域

扩张情报

全新 · 仅在 Pubrio

我们正在追踪 Peptron 的市场扩张

全球扩张

实时
阶段
探索中投入中进入中运营中

活动脉搏

最近 90 天内有 1 个信号。

最近 90 天
招聘
0
无活动
营销与公关
0
无活动
产品与技术
0
无活动
+2个类别已锁定
已显示 5 个中的 3 个
了解一下

关于 Peptron 的常见问题

关于 Peptron 的业务、市场和增长信号的快速解答。

SmartDepotTM is Peptron’s proprietary ultrasonic spray drying technology for the preparation of sustained release (SR) injectable microsphere formulation of drug. Recently, this long-acting technology has attracted the intense attention of global pharmaceutical companies since the costs for developing new medicines are soaring and patent expirations of many blockbuster drugs are just around the corner. SmartDepotTM is a next generation technology featuring various release profiles from 1 week to 6 months, showing high production yield and enabling mass production, differentiated from existing SR technology. SmartDepotTM is highly applicable to various peptide and small molecule drug. Patented technology ensures manufacturing and quality aspects of the competitive product development. Peptron has been developing anti-diabetes drug, anti-neurodegenerative disease drug, anti-acromegaly drug, anti-schizophrenia drug, which will be marketed in collaboration with global partners.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。